This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Oct 20;33(30):3365-6.

doi: 10.1200/JCO.2015.63.6118. Epub 2015 Aug 31.

Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer

Anthony V D'Amico¹

Affiliations

PMID: 26324374
DOI: 10.1200/JCO.2015.63.6118

Editorial

Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer

Anthony V D'Amico. J Clin Oncol. 2015.

. 2015 Oct 20;33(30):3365-6.

doi: 10.1200/JCO.2015.63.6118. Epub 2015 Aug 31.

Author

Anthony V D'Amico¹

Affiliation

¹ Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA adamico@partners.org.

PMID: 26324374
DOI: 10.1200/JCO.2015.63.6118

No abstract available

PubMed Disclaimer

Comment on

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.
Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB. Tosoian JJ, et al. J Clin Oncol. 2015 Oct 20;33(30):3379-85. doi: 10.1200/JCO.2015.62.5764. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324359 Free PMC article.

Similar articles

What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA, Cowan JE, Smith JA Jr, Carroll PR; CaPSURE Investigators. Barocas DA, et al. J Urol. 2008 Oct;180(4):1330-4; discussion 1334-5. doi: 10.1016/j.juro.2008.06.019. Epub 2008 Aug 15. J Urol. 2008. PMID: 18707731
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing.
Overholser S, Nielsen M, Torkko K, Cwilka D, Weaver B, Shi X, Leach RJ, Hernandez J, Huang T, Thompson IM Jr, Thompson IM 3rd. Overholser S, et al. J Urol. 2015 Sep;194(3):680-4. doi: 10.1016/j.juro.2015.01.089. Epub 2015 Jan 28. J Urol. 2015. PMID: 25636657
Active surveillance for prostate cancer: for whom?
Klotz L. Klotz L. J Clin Oncol. 2005 Nov 10;23(32):8165-9. doi: 10.1200/JCO.2005.03.3134. J Clin Oncol. 2005. PMID: 16278468 Review.
Integration of multiparametric MRI into active surveillance of prostate cancer.
Holtz JN, Tay KJ, Polascik TJ, Gupta RT. Holtz JN, et al. Future Oncol. 2016 Nov;12(21):2513-2529. doi: 10.2217/fon-2016-0142. Epub 2016 Jun 20. Future Oncol. 2016. PMID: 27322161 Review.
Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
Prasad SM, Gu X, Lipsitz SR, Nguyen PL, Hu JC. Prasad SM, et al. Cancer. 2012 Mar 1;118(5):1260-7. doi: 10.1002/cncr.26416. Epub 2011 Aug 5. Cancer. 2012. PMID: 21823112

See all similar articles

Cited by

Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials.
Kumar NB, Bahl S, Dhillon J, Poch M, Manley B, Li R, Schell M, Powsang J. Kumar NB, et al. Cancers (Basel). 2023 Feb 16;15(4):1257. doi: 10.3390/cancers15041257. Cancers (Basel). 2023. PMID: 36831597 Free PMC article.
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome.
Kumar NB, Hogue S, Pow-Sang J, Poch M, Manley BJ, Li R, Dhillon J, Yu A, Byrd DA. Kumar NB, et al. Cancers (Basel). 2022 Aug 18;14(16):3988. doi: 10.3390/cancers14163988. Cancers (Basel). 2022. PMID: 36010981 Free PMC article. Review.
Green tea extract for prevention of prostate cancer progression in patients on active surveillance.
Kumar NB, Dickinson SI, Schell MJ, Manley BJ, Poch MA, Pow-Sang J. Kumar NB, et al. Oncotarget. 2018 Dec 28;9(102):37798-37806. doi: 10.18632/oncotarget.26519. eCollection 2018 Dec 28. Oncotarget. 2018. PMID: 30701033 Free PMC article. Review.
Trends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?
Parikh RR, Kim S, Stein MN, Haffty BG, Kim IY, Goyal S. Parikh RR, et al. Cancer Med. 2017 Oct;6(10):2410-2418. doi: 10.1002/cam4.1132. Epub 2017 Sep 18. Cancer Med. 2017. PMID: 28925011 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program